News / Events

Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy

Annual SVB Leerink Global Healthcare Conference

Feb 24, 2021 • 11:20am - 11:50am EST

Clinical Investigator Webinar to Review ABO-102 and ABO-101 Clinical Data Presented at the 17th Annual WORLDSymposium™

Feb 16, 2021 • 1:00pm EST